Mangoceuticals, Inc. — Revenue by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/f1a502e0-b6df-4b35-a782-c9c0910da05b/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $456.0k | 2025-01-01 – 2025-12-31 | evidence 0001493152-26-014478 |
| FY 2024 | $615.9k | 2024-01-01 – 2024-12-31 | evidence 0001641172-25-000085 |
| FY 2023 | $731.5k | 2023-01-01 – 2023-12-31 | evidence 0001493152-24-012508 |
| FY 2022 | $8.9k | 2022-01-01 – 2022-12-31 | evidence 0001493152-24-012508 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Mangoceuticals, Inc. — all facts · Net Income · Operating Income